U.S. federal trademark · Serial No. 79042017 · Reg. No. 3576339
Pharmaceutical preparations for the prevention and treatment of cancer, inflammatory disorders, autoimmune disorders, infectious diseases, neurodegenerative disorders and respiratory disorders which can be treated or ameliorated by antibodies binding to or blocking of a target antigen
Technological services, namely, technology research in the field of human monoclonal antibodies; Pharmaceutical research and development in the field of human monoclonal antibodies
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.